Barbara Rentroia‐Pacheco

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Alexander M.M. Eggermont, Domenico Bellomo, Suzette M. Arias‐Mejias et al. · European Journal of Cancer · 2020 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study

Ahmed Yousaf, Félicia Tjien-Fooh, Barbara Rentroia‐Pacheco et al. · International Journal of Dermatology · 2021 · 39 citations · Full text

Medicine, Oncology, Pathology +17

Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary

Iva Johansson, Dennie Tempel, Jvalini Dwarkasing et al. · European Journal of Surgical Oncology · 2021 · 35 citations · Full text

Medicine, Oncology, Pathology +17

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

Barbara Rentroia‐Pacheco, Selin Tokez, Edo M. Bramer et al. · EClinicalMedicine · 2023 · 30 citations · Full text

Medicine, Dermatology, Oncology +17

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse

Evalyn E.A.P. Mulder, Iva Johansson, Dirk J. Grünhagen et al. · Cancers · 2022 · 28 citations · Full text

Medicine, Oncology, Pathology +17